Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024 NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Cellectis (the...
Cellectis Reports Financial Results for First Quarter 2024 • Cellectis announced completion of the additional equity investment of $140M by...
Cellectis publiera ses résultats financiers du premier trimestre 2024 le 28 mai 2024 NEW YORK, 27 mai 2024 (GLOBE NEWSWIRE) -- Cellectis...
Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement...
Cellectis annonce la réalisation de l’investissement additionnel d’AstraZeneca Réalisation de l’investissement additionnel de 140 millions de...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.